Ireland vs Malta: Share of E. coli infections resistant to cephalosporins
Ireland
10.5%
in 2022
Malta
13.3%
in 2022
Ireland rank
38th
Malta rank
36th
Share of E. coli infections resistant to cephalosporins over time
- Ireland
- Malta
How they compare
Malta currently reports 13.3% against 10.5% in Ireland, a difference of 2.8%.
That makes Malta's figure about 1.3 times Ireland's.
Across all 6 years both countries report, Malta has been ahead every year.
Ireland ranks 38th and Malta ranks 36th of 46 countries.
Malta has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Ireland | Malta | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 12.5% | 16.8% | 4.3% | Malta |
| 2020s | 10.3% | 12.8% | 2.4% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Ireland or Malta?
- Malta, at 13.3% against 10.5% in Ireland as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Ireland and Malta?
- 2.8%, with Malta ahead.
- How many years of comparable data are there for Ireland and Malta?
- 6 years are reported by both, from 2017 to 2022.
- How do Ireland and Malta rank globally for share of e. coli infections resistant to cephalosporins?
- Ireland ranks 38th and Malta ranks 36th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).